Skip to content

CDXS

Codexis, Inc.

NASDAQ · Healthcare · Biotechnology · US

$1.44
+1.06%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue77.7M70.4M59.3M70.1M138.6M
Cost of Revenue12.7M9.3M16.3M12.8M38.0M
Gross Profit65.0M61.0M43.1M57.3M100.6M
Operating Expenses
R&D Expense46.8M52.3M46.3M58.9M80.1M
SG&A Expense42.5M47.1M55.1M53.3M52.2M
General & Admin Expense10.9M53.0M
Selling & Marketing Expense300.0K
Other Expenses165.0K13.3M3.2M
Total Operating Expenses89.3M99.4M101.6M125.4M135.4M
Cost and Expenses101.9M108.7M117.9M138.2M173.5M
Operating Income (EBIT)(24.3M)(38.3M)(58.5M)(68.1M)(34.9M)
Non-Operating
Interest Income2.5M2.6M3.7M4.2M1.4M
Interest Expense1.3M4.8M
Net Interest Income1.2M(2.2M)3.7M4.2M1.4M
Other Non-Op Income/Expense(6.4M)(5.6M)(6.7M)(8.1M)1.6M
Non-Operating Income (excl Interest)5.1M782.0K(165.0K)(13.3M)(3.2M)
EBT (Pre-Tax Income)(30.7M)(43.9M)(65.2M)(76.2M)(33.3M)
Income Tax Expense72.0K47.0K34.0K69.0K276.0K
Bottom Line
Net Income(30.7M)(44.0M)(65.3M)(76.2M)(33.6M)
Earnings from Cont. Ops(30.7M)(44.0M)(65.3M)(76.2M)(33.6M)
Earnings from Discont. Ops
Bottom Line Net Income(30.7M)(44.0M)(65.3M)(76.2M)(33.6M)
Per Share
Basic EPS($0.34)($0.50)($0.89)($1.12)($0.51)
Diluted EPS($0.34)($0.50)($0.89)($1.12)($0.51)
Revenue Per Share$0.85$0.81$0.81$1.03$2.12
Shares
Basic Shares Outstanding91.1M87.1M73.4M68.1M65.3M
Diluted Shares Outstanding91.1M87.1M73.4M68.1M65.3M
Profitability Metrics
EBITDA(21.6M)(33.9M)(53.4M)(49.3M)(26.3M)
D&A7.7M5.2M4.9M5.5M5.4M
EBIT(29.4M)(39.1M)(58.4M)(54.8M)(31.7M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026